Search Results - "LEITER, E. H."

Refine Results
  1. 1

    Mice with targeted gene, disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions by LEITER, E. H

    Published in Diabetologia (01-03-2002)
    “…The mouse has been a favoured organism for molecular manipulation in studies seeking to establish the genetic bases and pathophysiologic mechanisms underlying…”
    Get full text
    Journal Article
  2. 2

    The NOD mouse model of type 1 diabetes: As good as it gets? by Atkinson, Mark A, Leiter, Edward H

    Published in Nature medicine (01-06-1999)
    “…Of the two well-known rodent models of human type 1 diabetes (the non-obese diabetic mouse and the BioBreeding rat) the mouse has become the model of choice…”
    Get full text
    Journal Article
  3. 3

    Maternal environment and genotype interact to establish diabesity in mice by Reifsnyder, P C, Churchill, G, Leiter, E H

    Published in Genome research (01-10-2000)
    “…Obesity, a major risk factor for type II diabetes, is becoming more prevalent in Western populations consuming high calorie diets while expending less energy…”
    Get full text
    Journal Article
  4. 4

    mt-Nd2 allele of the ALR/Lt mouse confers resistance against both chemically induced and autoimmune diabetes by MATHEWS, C. E, LEITER, E. H, SPIRINA, O, BYKHOVSKAYA, Y, GUSDON, A. M, RINGQUIST, S, FISCHEL-GHODSIAN, N

    Published in Diabetologia (01-02-2005)
    “…ALR/Lt, a mouse strain with strong resistance to type 1 diabetes, is closely related to autoimmune type 1 diabetes-prone NOD/Lt mice. ALR pancreatic beta cells…”
    Get full text
    Journal Article
  5. 5

    Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease by Jurisic, G, Sundberg, J P, Bleich, A, Leiter, E H, Broman, K W, Buechler, G, Alley, L, Vestweber, D, Detmar, M

    Published in Genes and immunity (01-04-2010)
    “…Inflammatory bowel disease (IBD) is a chronic debilitating disease resulting from a complex interaction of multiple genetic factors with the environment. To…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice by Serreze, DV, Gaskins, HR, Leiter, EH

    Published in The Journal of immunology (1950) (15-03-1993)
    “…Although T lymphocytes are the ultimate effectors of pancreatic beta cell destruction in autoimmune insulin-dependent diabetes, previous work has established…”
    Get full text
    Journal Article
  8. 8

    Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes by Wicker, L S, Leiter, E H, Todd, J A, Renjilian, R J, Peterson, E, Fischer, P A, Podolin, P L, Zijlstra, M, Jaenisch, R, Peterson, L B

    Published in Diabetes (New York, N.Y.) (01-03-1994)
    “…Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. L S Wicker , E H Leiter , J A Todd , R J Renjilian , E Peterson , P A Fischer , P…”
    Get full text
    Journal Article
  9. 9

    Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors by Christianson, S. W., Shultz, L. D., Leiter, E. H.

    Published in Diabetes (New York, N.Y.) (01-01-1993)
    “…Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic…”
    Get full text
    Journal Article
  10. 10

    The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency by PROCHAZKA, M, REX GASKINS, H, SHULTZ, L. D, LEITER, E. H

    “…Homozygosity for the severe combined immunodeficiency (scid) mutation results in a block in T- and B-lymphocyte development. An unusually high incidence of…”
    Get full text
    Journal Article
  11. 11

    Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice by RAPOPORT, M. J, JARAMILLO, A, ZIPRIS, D, LAZARUS, A. H, SERREZE, D. V, LEITER, E. H, CYOPICK, P, DANSKA, J. S, DELOVITCH, T. L

    Published in The Journal of experimental medicine (01-07-1993)
    “…Beginning at the time of insulitis (7 wk of age), CD4+ and CD8+ mature thymocytes from nonobese diabetic (NOD) mice exhibit a proliferative unresponsiveness in…”
    Get full text
    Journal Article
  12. 12

    Resistance of ALR/Lt islets to free radical-mediated diabetogenic stress is inherited as a dominant trait by MATHEWS, C. E, LEITER, E. H

    Published in Diabetes (New York, N.Y.) (01-11-1999)
    “…Resistance of ALR/Lt islets to free radical-mediated diabetogenic stress is inherited as a dominant trait. C E Mathews and E H Leiter The Jackson Laboratory,…”
    Get full text
    Journal Article
  13. 13

    Hematopoietic Stem-Cell Defects Underlying Abnormal Macrophage Development and Maturation in NOD/Lt Mice: Defective Regulation of Cytokine Receptors and Protein Kinase C by Serreze, David V., Gaedeke, Jens W., Leiter, Edward H.

    “…The immunopathogenesis of autoimmune insulin-dependent diabetes in NOD mice entails defects in the development of macrophages (Mos) from hematopoietic…”
    Get full text
    Journal Article
  14. 14

    The genetics of diabetes susceptibility in mice by Leiter, E H

    Published in The FASEB journal (01-09-1989)
    “…The factors associated with a diabetes-susceptible genotype in mice exhibiting various forms of heritable glucose intolerance syndromes are discussed. Genetic…”
    Get more information
    Journal Article
  15. 15

    Metalloprotease-Mediated Shedding of Enzymatically Active Mouse ecto-ADP-ribosyltransferase ART2.2 Upon T Cell Activation by Kahl, Sarah, Nissen, Marion, Girisch, Roman, Duffy, Ted, Leiter, Edward H, Haag, Friedrich, Koch-Nolte, Friedrich

    Published in The Journal of immunology (1950) (15-10-2000)
    “…T cells proteolytically shed the ectodomains of several cell surface proteins and, thereby, can alter their responsiveness and can release soluble…”
    Get full text
    Journal Article
  16. 16

    Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells by BRIDGETT, M, CETKOVIC-CVRLJE, M, O'ROURKE, R, YUGUANG SHI, NARAYANSWAMI, S, LAMBERT, J, RAMIYA, V, BAEKKESKOV, S, LEITER, E. H

    Published in Diabetes (New York, N.Y.) (01-12-1998)
    “…Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. M Bridgett , M Cetkovic-Cvrlje ,…”
    Get full text
    Journal Article
  17. 17

    Experimental Models to Study Molecular Mechanisms Underlying Intestinal Inflammation by ELSON, C. O., CONG, Y., BRANDWEIN, S., WEAVER, C. T., McCABE, R. P., MÄHLER, M., SUNDBERG, J. P., LEITER, E. H.

    Published in Annals of the New York Academy of Sciences (01-11-1998)
    “…Experimental animal models, particularly the newer mouse models, have convincingly demonstrated that CD+ T cells play a central role in chronic intestinal…”
    Get full text
    Journal Article
  18. 18

    NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse by Hamaguchi, K., Gaskins, H. R., Leiter, E. H.

    Published in Diabetes (New York, N.Y.) (01-07-1991)
    “…NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. K Hamaguchi , H R Gaskins and E H Leiter Jackson Laboratory, Bar Harbor, Maine…”
    Get full text
    Journal Article
  19. 19

    Conditioning the genome identifies additional diabetes resistance loci in Type I diabetes resistant NOR Lt mice by Reifsnyder, P C, Li, R, Silveira, P A, Churchill, G, Serreze, D V, Leiter, E H

    Published in Genes and immunity (01-09-2005)
    “…While sharing the H2g7 MHC and many other important Type I diabetes susceptibility (Idd) genes with NOD mice, the NOR strain remains disease free due to…”
    Get full text
    Journal Article
  20. 20

    Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies by Serreze, D.V, Leiter, E.H

    Published in The Journal of immunology (1950) (01-06-1988)
    “…Nonobese diabetic (NOD) is an inbred mouse strain susceptible to development of T cell-mediated autoimmune diabetes. The strain is characterized by high…”
    Get full text
    Journal Article